Enterically coated cysteamine, cystamine and derivatives thereof
AssigneeThe Regents of the University of California
InventorsRanjan Dohil, Jerry Schneider
Life of this patent
Estimating the term…
Abstract
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
Claims8
A composition comprising (a) cysteamine, or a pharmaceutically acceptable salt thereof, or cystamine, or a pharmaceutically acceptable salt thereof, and (b) one or more materials that provide increased delivery of cysteamine or cystamine to the small intestine.
A composition comprising an enterically coated cysteamine, or cysteamine derivative, or cystamine or cystamine derivative.
Dependencies are inferred from the claim text.